REVIEW CLASSIFICATION PROSTATE CARCINOMA ACCORDING TO WORLD HEALTH ORGANIZATION 2016

Nguyễn Thu Thủy; Hoàng Quốc Huy; Phạm Thị Ngọc Mai; Nguyễn Đức Thắng

REVIEW CLASSIFICATION PROSTATE CARCINOMA ACCORDING TO WORLD HEALTH ORGANIZATION 2016

About this article

Received: 07/10/19 Revised: 13/01/20 Published: 31/01/20

Authors

1. Nguyen Thu Thuy , TNU - University of Medicine and Pharmacy
2. Hoang Quoc Huy, TNU - University of Medicine and Pharmacy
3. Pham Thi Ngoc Mai, TNU - University of Medicine and Pharmacy
4. Nguyen Duc Thang, TNU - University of Medicine and Pharmacy

Abstract

The classification of prostate carcinoma has undergone several major modifications nearly 40 years. Nowadays, in Vietnam and many countries in the world still apply the histopathological classification according to the World Health Organization 2004. The classification by the World Health Organization in 2004 has quite enough classification of tips Pre-cancer lesion histopathology and basic understanding of molecular biology in prostate cancer. In 2016, the World Health Organization made important updates compared to 2004 on new histological, new variants of cystic adenocarcinoma, and new immune tissue markers, for diagnostics, risk stratification and histological modifications on the Gleason point ladder. The histopathological classification according to the World Health Organization 2016 is a detailed classification system which has practical significance should be widely used in Vietnam.

Keywords

histopathological classification; prostate; prostate carcinoma; immunohistochemistry; Gleason point ladder

Full Text:

PDF (Tiếng Việt)

References

[1]. IARC, “Prostate source: Globocan 2018”, March, 2019. [Online]. Available: https://gco.iarc.fr/today/data/factsheets/cancers/27-Prostate-fact-sheet.pdf/. [Accessed Oct. 1, 2019].

[2]. IARC, “Viet Nam source: Globocan 2018”, May, 2019. [Online]. Available: https://gco.iarc.fr/today/data/factsheets/populations/704-viet-nam-fact-sheets.pdf/. [Accessed Oct. 1, 2019].

[3]. K. T. Mai et al., Instructions for diagnosis and treatment of prostate cancer. Medical publishing house, Ha Noi (In Vietnamese), 2014, pp. 8-9,.

[4]. A. Bocking, and E. Sinagowitz, “Histologic grading of prostatic carcinoma,” Pathol Res. Pract, 168(3), pp. 115-125, 1980.

[5]. A. Weidhase, and E. Kunze, “Incidence and morphology of coexisting carcinomas of the urinary bladder and prostate,” Verh Dtsch Ges Pathol, 77, pp. 142-146, 1993.

[6]. J. N. Eble et al., Pathology and Gennetics of Tumours of the Urinary System and Male Genital Organs, WHO Classification of of Tumours of the Urinary System and Male Genital Organs, 3th, 2004.

[7]. T. M. Ulbright et al., WHO Classification of of Tumours of the Urinary System and Male Genital Organs, WHO Classification of of Tumours of the Urinary System and Male Genital Organs, 4th, 2016, pp. 189-226.

[8]. D. F. Gleason, “Classification of prostatic carcinomas,” Cancer Chemother Rep., 50(3), pp. 125-128, 1966.

[9]. J. I. Epstein et al., “The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma,” Am J. Surg Pathol, 29(9), pp. 1228-1242, 2005.

[10]. P. Helpap and L. Egevad, “The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens,” Virchows Arch, 449(6), pp. 622-627, 2006.

[11]. A. Billis et al., “The value of the 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system as a predictor of biochemical recurrence after radical prostatectomy,” Int. Urol Nephrol, 46(5), pp. 935-940, 2014.

[12]. J. I. Epstein et al., “The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System,” Am J. Surg Pathol, 40(2), pp. 244-252, 2016.

[13]. H. Samaratunga et al., “From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer,” Scand J. Urol, 50(5), pp. 325-329, 2016.

[14]. J. I. Epstein et al., “A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score,” Eur Urol, 69(3), pp. 428-435, 2016.

[15]. P. A. Humphrey et al., “The 2016 WHO classification of tumor of the Urinary system and male genital organs-Part B,” Prostate and Bladder Tumor. Eur Urol, 70(1), pp. 106-119, 2016.

[16]. G. A. Frank et al., “A new WHO classification of prostate tumors,” Scand J. Urol, 78(4), pp. 32-42, 2016.

[17]. K. Inamura, “Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification,” Oncotarget, 18(2), pp. 14723-14737, 2018.

[18]. J. Liu et al., “The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patient with high-risk prostate cancer: a single-center retrospective study,” Cancer Management and Research, 11, pp. 6521-6529, 2019.

[19]. J. Grogan et al., “Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatetomy with long-term follow-up,” BJU Int., 120(5), pp. 651-658, 2017.

[20]. A. Offermann et al., “Prognostic value of the New Prostate Cancer International Society of Urological Pathology Grade Groups,” Frontiers in Medicine, 157(4), pp. 1-7, 2017.

Refbacks

There are currently no refbacks.



Remember me